To address this question, SNAI3 expression was assessed by qRT-PCR in a cohort of primary human tumors (n = 44) encompassing four different carcinoma types (colon, lung, ESCC, kidney), as compared to healthy tissues or normal cell counterparts. Here, SNAI3 is linked to carcinoma.